{"id":996,"date":"2023-09-01T17:58:55","date_gmt":"2023-09-01T17:58:55","guid":{"rendered":"https:\/\/clinicamaddarena.com.br\/?p=996"},"modified":"2023-10-08T07:22:10","modified_gmt":"2023-10-08T07:22:10","slug":"pregabalin-uses-interactions-mechanism-of-action-70","status":"publish","type":"post","link":"https:\/\/clinicamaddarena.com.br\/blog\/pregabalin-uses-interactions-mechanism-of-action-70\/","title":{"rendered":"Pregabalin: Uses, Interactions, Mechanism of Action DrugBank Online"},"content":{"rendered":"

Pregabalin: Uses, Interactions, Mechanism of Action DrugBank Online<\/h1>\n

In this study, 105 patients received LYRICA and 70 patients received placebo for up to 14 days. Approximately 2.5% of patients receiving LYRICA and no patients receiving placebo in trials of adjunctive therapy for partial-onset seizures discontinued prematurely due to adverse reactions. In the LYRICA treatment group, the adverse reactions leading to discontinuation were somnolence (3 patients), worsening of epilepsy (1 patient), and hallucination (1 patient).<\/p>\n